Sensex rises 259 points to end at 2-week high

BSE Mid-Cap index gained 1.1%, and the BSE Small-Cap index added 1.3%

Image via Shutterstock
<a href="http://www.shutterstock.com/pic-146496278.html" target="_blank">Image</a> via Shutterstock
Surabhi Roy Mumbai
Last Updated : Nov 30 2016 | 4:57 PM IST
Benchmark indices extended gains and ended firm for four straight trading sessions supported by strong global cues on upbeat US growth news while buying among rate-sensitive sectors also aided the rally.

The S&P BSE Sensex settled the day at 26,653, up 259 points, while the broader Nity50 closed at 8,225, up 82 points. Broader markets outperformed the benchmark indices. BSE Mid-Cap index gained 1.1%, and the BSE Small-Cap index added 1.3%.

ALSO READ: DIIs pump over Rs 17,000 crore in markets in November

Meanwhile, HSBC maintained "overweight" rating on Indian equities, saying "fundamentals are strong".

"Going forward we believe a short-term oversold rally is due in the market and the market is likely to move up to test next resistance around 8,400 level. Holding above the 8,000 and move above 8,200 level bulls is likely to regain its control back," said Rohit Gadia, Founder & CEO, CapitalVia Global Research.

Among macro economic data, India's gross domestic product (GDP) for the quarter ended September 2016 (Q2) is slated to be released today. Fitch Ratings also lowered India’s GDP growth forecast for this fiscal to 6.9% from 7.4%, saying there will be “temporary disruptions” to economic activity post demonetisation.

ALSO READ: Chilled by demonetisation, India to take cold comfort from strong GDP

In a move aimed at protecting “the innocent farmers and rural account holders of PMJDY (the Pradhan Mantri Jan Dhan Yojana) from activities of money launderers and legal consequences under the Benami Property Transaction & Money Laundering laws”, the Reserve Bank of India (RBI) has placed a limit of Rs 10,000 on monthly withdrawals from Jan Dhan bank accounts.

On the global front, Asian and European stocks rose as investors awaited the conclusion of a highly-anticipated Organization of the Petroleum Exporting Countries (OPEC) meeting later in the day. OPEC are set to meet in Vienna, Austria today and market men are awaiting decision regarding an oil production cut.

Oil jumped more than 5% on Wednesday, after the Saudi oil minister said an agreement among OPEC members on cutting output was close, putting the price on course for its biggest one-day move since April.

ALSO READ: Iran, Iraq at loggerheads with Saudis ahead of OPEC meeting

US stocks closed higher yesterday with the Nasdaq touching a record, but the market failed to make much headway as oil futures slumped ahead of a key meeting of major crude producers.

Back home, domestic institutional investors (DIIs) – including banks, domestic financial institutions, insurance, new pension scheme and mutual funds – have pumped in net Rs 17,600 crore into the Indian markets during the month till Tuesday—the highest since the Bombay Stock Exchange (BSE) started maintaining the data since calendar year 2005.

BUZZING STOCKS

Among key stocks, ICICI Bank, Maruti Suzuki, SBI, L&T and ONGC rose between 2%-4%. On the losing side, GAIL, RIL, Coal India, M&M and NTPC were down 0.1%-1%.

ALSO READ: Demonetisation impact unlikely to last long: Gaurang Shah

Jubilant Life Sciences, Syngene International, Essel Propack, Shemaroo Entertainment, Bharat Electronics and Power Finance Corporation (PFC) were among 14 stocks from the BSE500 and Smallcap index that hit their respective 52-week highs on the BSE today.

Shares of Amtek Group companies Amtek Auto, Metalyst Forgings and Castex Technologies ended higher by up to 8% on BSE after the board of these companies approved the infusion of fresh capital by investors and restructuring of the debt as proposed by the investors.


IDFC Bank dipped around 4% to Rs 68.35 on the NSE after more than 2% equity of the bank changed hands through block deals.

Sarda Energy & Minerals ended higher by over 6% on the BSE after the restoration of operations at iron ore mine of the company.

Vivimed Labs surged over 8% after the company said its 'Finished Dosage Form' (FDF) manufacturing facility located in Alathur, near Chennai has had a favourable outcome post its US Food and Drug Administration (USFDA) inspection.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 30 2016 | 3:35 PM IST

Next Story